A 67-year-old male with behavioral and language problems

Slides:



Advertisements
Similar presentations
“Getting to Know Me” “Getting to Know Me” Enhancing skills in the care of people with dementia in general hospitals. © Greater Manchester West Mental Health.
Advertisements

Frontotemporal Dementia
Parkinson’s Cognitive Problems versus Other Neurological Diseases 14 February 2015 Carole A. Mazurowski, PhD Health Psychology & Neuropsychology 6565 Americas.
Dementia with Lewy Bodies
DEMENTIA JOE BEDFORD IBRAHIM ELSAFY ESCALIN PEIRIS.
Dementia. Definition Loss of function in multiple cognitive abilities Assuming the individual had normal abilities before the onset Many of the 70 recognized.
How Alzheimer’s Disease Differs from Frontal Temporal Lobe Dementia (Pick’s Disease) Josepha A. Cheong, MD University of Florida Departments of Psychiatry.
NHPA’s Chapter 3. National Health Priority Areas A collaborative initiative endorsed by the Commonwealth and all state and territory governments, which.
Kimiko Domoto-Reilly, MD 1,2,5 Daisy Sapolsky, MS, CCC-SLP 1,3,4 Aly Negreira, BA 1,3 1 Frontotemporal Disorders Unit, Departments of 2 Neurology, 3 Psychiatry,
Selective impairment in the retrieval of family relationships in person identification: A case study of delusional misidentification Abe, N., Ishii, H.,
M. Alzheimer. Etiopatogenesis patological proteins u neuritic plaques u  amyloid u amyloid precursor protein (APP)  sekretase  sekretase  amyloid.
Non-Alzheimer’s Dementias
Parkinson’s Plus By: Glen Estrosos.
Alzheimer’s Disease The most common cause of Dementia –Progressive Memory Loss Plus loss in one other area of cognition: Perception Attention Language/Symbols.
Jack Twersky, MD Medical Director CLC Durham.  Memory impairment and at least one of the following  Aphasia  Apraxia  Agnosia  Executive function.
2010 MEETING, PHILADELPHIA AMERICAN ASSOCIATION OF NEUROPATHOLOGISTS DSS CASE # 11 J-M BILBAO, B YOUNG and N LIU SUNNYBROOK HOSPITAL UNIVERSITY OF TORONTO.
 Alzheimer's disease (AD), also known as Senile Dementia of the Alzheimer Type (SDAT) or simply Alzheimer’s is the most common form of dementia. This.
The Dementias Dr Giles Richards Consultant Psychiatrist CFT.
억제적 반응통제 기능의 신경해부학 연구 : 활성화 및 신경화학적 두뇌 기능 영상 PET 연구 Functional Neuroanatomical Study of Inhibitory Response- Control: Activation and Neurochemical PET.
Focal Syndromes Dr Stephen Pearson Consultant in Old Age Psychiatry Devon Partnership Trust.
A 53-year-old male with clumsiness Leonidas Arvanitis, M.D. Neuropathology Fellow, PGY-6.
CSD 2230 HUMAN COMMUNICATION DISORDERS Topic 6 Language Disorders Adult Disorders Traumatic Brain Injury Dementia.
Dementia Care Wendy Burnett CNS for Older People.
Dementia Nicholas Cascone, PA-C.
Pathologic features of AD. Pathologic changes (specifically plaques, tangles, and the associated neuronal loss and glial reaction) a. Are evident first.
Kimiko Domoto-Reilly, MD Cognitive / Behavioral Neurology Fellow Massachusetts General Hospital & Brigham and Women’s Hospital.
Mariano Musacchio 1 François Sellal 2 Frédéric Blanc 2 Jean-Marc Michel 2 Stephan Kremer 3 Jean-Louis Dietemann 3 1 Department of Neuroradiology - CHG.
CPC #7: Pathology Barbara J. Crain, MD, PhD February 25, 2009.
Types of Dementia Dr Bernie Coope Associate Medical Director/Honorary Senior Lecturer, Worcester University Association for Dementia Studies.
CASES SERIES BRAIN FDG PET SCAN IN DEMENTIA PATIENTS
BACKGROUND Screening for subclinical TDP43 neuropathology in autoimmune conditions: a pilot study Natasha Clarke, Nidhi Sofat, Lena Assi and Peter GarrardContact:
Frontotemporal Lobar Degeneration:
This is an umbrella term, not a disease in its own right. It is a term used for a large group of symptoms that adversely affect the brain and can be caused.
DEGENERATIVE DISEASES is a disease in which the function or structure of the affected tissues or organs will progressively deteriorate over time, whether.
Neurodegenerative Neuropath. The Neurodegenerates  Alzheimer’s Disease  Parkinson’s Disease  Lewy Body Dementia  Multiple Systems Atrophy  FTD /
DEMENTIA 1/6/16 DR TONY O’BRIEN MD FRCP. Dementia Common – 700,000 sufferers in the UK Common – 700,000 sufferers in the UK Prevalence increases with.
Dementia Jaqueline Raetz, M.D.. Types of Dementia Alzheimer Dementia 70% Lewy Body Dementia about 22% Vascular Dementia 17% Frontotemporal Dementia Overall.
59 year old man w visual hallucinations
The ageing brain Volume reduction: begins around 50 with a loss of brain weight of around 2-3% per decade Changes in nerve cell numbers and size - various.
Dementia Jaqueline Raetz, M.D..
FRONTOTEMPORAL DEMENTIA IN A CASE OF SUICIDAL HANGING
By: Johanna Miner, Kendra Hobbs and Ainsley MAcDonald
A Sporadic Case of Progressive Non-Fluent Aphasia
Dementia Jaqueline Raetz, M.D..
Frontotemporal dementia syndromes are united by underlying frontotemporal lobar degeneration pathology, which can be divided according to the presence.
Fig. 11. Algorithm for differential diagnosis of cognitive impaired subjects by employing structural imaging. AD = Alzheimer's disease, BG = basal ganglia,
A 66 year-old woman with progressive speech difficulty
Long Term Effects of Concussions
The clinical, neuroanatomical, and neuropathologic phenotype of TBK1-associated frontotemporal dementia: A longitudinal case report  Carolin A.M. Koriath,
Frontotemporal Dementia
Nat. Rev. Neurol. doi: /nrneurol
Figure 4 Cerebrospinal fluid levels of neurofilament light chain
Atypical Parkinsonian Syndromes
Nat. Rev. Neurol. doi: /nrneurol
Figure 2 Patterns of brain atrophy in Alzheimer disease
Keith A. Josephs, MD, MST, MSc  Mayo Clinic Proceedings 
Frontotemporal Dementia
Nat. Rev. Neurol. doi: /nrneurol
Case Study 87 Leonidas Arvanitis, MD
A 57-year-old male who was brought to the ER unresponsive
Case Study 86 Leonidas Arvanitis, MD
Figure 2 Grey matter atrophy in FTD
Mark S. Forman, Virginia M-Y. Lee, John Q. Trojanowski  Neuron 
Transmissible human proteopathies: an expanding field
CNS.
Case Study 83 Leonidas Arvanitis, MD
Patient 2- Alzheimer’s Disease
The Memory Assessment and Treatment Service (MATS)
R.A. Armstrong, P.L. Lantos, N.J. Cairns  Pathophysiology 
Presentation transcript:

A 67-year-old male with behavioral and language problems Leonidas Arvanitis, M.D. Neuropathology Fellow, PGY-6

History The patient was a 67-year-old male with a long standing history of progressive difficulty with language and thinking. His wife stated that his overall problems began approximately 17 years ago during which time he was drinking approximately 2 cases of beer per week. Approximately at that time he first started having "trouble placing words in sentences."

History Further cognitive evaluation revealed marked problems with language function and suggested that he had primary progressive aphasia. An MRI showed extensive temporal and frontal lobe atrophy. His MMSE was 20/30. The patient further declined and eventually died

Autopsy An autopsy was performed and showed the following (describe): http://library.med.utah.edu/WebPath/TUTORIAL/CNS/CNSDG008.html

Autopsy An autopsy was performed and showed the following (describe): Lobar atrophy involving the frontal (mostly) and temporal lobes. “Knife-like” gyri. http://library.med.utah.edu/WebPath/TUTORIAL/CNS/CNSDG008.html

This is a section from the frontal lobe. What do you see? Frontal lobe. (Click here for H&E)

This is a section from the frontal lobe. What do you see?

This is a section from the frontal lobe. What do you see? Eosinophilic cytoplasmic inclusions Neuronal loss

This is a section from the frontal lobe. What do you see? Severe gliosis

This is a section from the frontal lobe. What do you see?

This is a section from the frontal lobe. What do you see? Vacuolization of the superficial cortical layer

This is a section from the frontal lobe. What do you see?

This is a section from the frontal lobe. What do you see? Balloon cell

Question: In the work up of a neurodegenerative disease what immunohistochemical stains are helpful in highlighting intracellular inclusions?

Answer Tau A-synuclein TDP-43 Alzheimer’s disease Pick’s disease Progressive Supranuclear Palsy Corticobasal degeneration A-synuclein Parkinson’s disease TDP-43 FTLD-TDP

Question: The intracellular inclusions on this case were negative for a-synuclein and TDP-43, but Tau showed the following staining pattern: Click here to view Tau stain

Tau stain

How are these spherical, intraneuronal inclusions known as?

Pick bodies

Answer Pick bodies are spherical intraneuronal cytoplasmic inclusions They are most frequently found in the frontal and temporal lobes and limbic cortex

Question What is the most likely diagnosis of a patient with behavioral and language difficulties that showed these associated pathologic features?

Answer FTLD-Tau: Pick’s disease

Question What are the clinical features of Frontotemporal Lobar Degeneration (FTLD)?

Answer The 3 main clinical syndromes are Behavioral variant Cognitive decline and changes in social and personal conduct Progressive nonfluent aphasia (PNFA) Problems in word retrieval but with preservation of comprehension Semantic dementia Patients have impairment of the realm of memory that relates to the meaning of verbal and visual inputs

Question What are the pathologic subtypes of FTLD?

Anwser FTLD-Tau FTLD-TDP FTLD-FUS FTLD-UPS FTLD-ni (no inclusions)